Drugs / FTP-198
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04526496 | Feb → Nov 2020 | — | Sichuan Haisco Pharmaceutical Group Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FTP-198 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04526496 ↗ |
| Route | Oral | “oral suspension” NCT04526496 ↗ |